CVS Health (CVS) Tops Q4 EPS by 7c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $93.94 -0.85%
EPS Growth %: +3.1%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: +3.1%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q4 EPS of $1.99, $0.07 better than the analyst estimate of $1.92. Revenue for the quarter came in at $83.85 billion versus the consensus estimate of $76.33 billion.
GUIDANCE:
CVS Health sees FY2023 EPS of $8.70-$8.90, versus the consensus of $8.86.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Plumas Bancorp (PLBC) Tops Q3 EPS by 15c
- Moody's Corp. (MCO) Misses Q3 EPS by 11c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
